Twist Bioscience Stock

Twist Bioscience Employees 2024

Twist Bioscience Employees

414

Ticker

TWST

ISIN

US90184D1000

WKN

A2N7L2

In 2024, Twist Bioscience employed 414 people, a 0% change from the 414 number of employees in the previous year.

Twist Bioscience Aktienanalyse

What does Twist Bioscience do?

Twist Bioscience Corp is a company specializing in the production and applications of synthetic DNA. It was founded in 2013 and is based in San Francisco, California, USA. The company utilizes proprietary technologies to cost-effectively produce high-quality and high-quantity synthetic DNA. The company operates in three business areas: DNA synthesis, biopharmaceuticals, and data storage. The DNA synthesis division is the core of the company and involves the production of synthetic DNA for applications in various industries, including medicine, agricultural science, biotechnology, plastic engineering, and others. The company manufactures customized DNA synthesis products tailored to the needs of its customers, allowing them to accelerate and optimize their research and development projects. Twist Bioscience has also developed a proprietary technology called "Twist Biosensor" that enables rapid and cost-effective analysis of genetic variations. The biopharmaceutical division focuses on the development of therapeutics and diagnostics based on synthetic DNA. Twist Bioscience develops antibodies and proteins that can be used in cancer and immunotherapy, as well as diagnostics. In the data storage field, Twist Bioscience develops solutions for storing large amounts of data on DNA. This technology utilizes the dense and stable structure of DNA to securely and reliably store data in the long term. Twist Bioscience's DNA synthesis products are utilized by researchers, companies, and public institutions in various industries. Customers value not only the wide product portfolio but also the high quality and precision of the products, as well as the speed of order processing. The company operates a number of manufacturing facilities near its customers in Europe and Asia to ensure fast and efficient delivery of its products. This allows Twist Bioscience to have a strong position in the global market. In recent years, the company has achieved significant milestones. In 2018, Twist Bioscience went public and raised a total of $70 million through its IPO. The company has also established partnerships with various other companies and institutions to develop new applications and products. Overall, Twist Bioscience is a growing company specializing in the production and applications of synthetic DNA. With its wide range of high-quality and customized DNA synthesis products, as well as its innovative solutions in the biopharmaceutical and data storage sectors, the company has established a strong market position. Twist Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Twist Bioscience's Employee Base

Twist Bioscience's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Twist Bioscience's operational capacity and future potential.

Year-to-Year Comparison

Assessing Twist Bioscience's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Twist Bioscience's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Twist Bioscience’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Twist Bioscience stock

How many employees does Twist Bioscience have this year?

Twist Bioscience has 414 undefined employees this year.

How many employees did Twist Bioscience have compared to the previous year?

Compared to the previous year, Twist Bioscience had 0% more employees.

What impact did the number of employees have on the company Twist Bioscience?

The number of employees has a direct impact on the efficiency and productivity of Twist Bioscience. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Twist Bioscience?

The number of employees can also have an impact on investors of Twist Bioscience, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Twist Bioscience affect the company?

An increase in equity of Twist Bioscience can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Twist Bioscience's equity affect the company?

A reduction in equity of Twist Bioscience can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Twist Bioscience?

Some factors that can influence the equity of Twist Bioscience include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Twist Bioscience so important for investors?

The equity of Twist Bioscience is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Twist Bioscience influence the company?

The number of employees at Twist Bioscience can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Twist Bioscience evolved in recent years?

In recent years, the number of employees at Twist Bioscience has changed by 0.

How many employees does Twist Bioscience currently have?

Twist Bioscience currently has 414 undefined employees.

Why is the number of employees important for investors of Twist Bioscience?

The number of employees is important for investors of Twist Bioscience as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Twist Bioscience take to change the number of employees?

To change the number of employees, Twist Bioscience can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Twist Bioscience pay?

Over the past 12 months, Twist Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Twist Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Twist Bioscience?

The current dividend yield of Twist Bioscience is .

When does Twist Bioscience pay dividends?

Twist Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Twist Bioscience?

Twist Bioscience paid dividends every year for the past 0 years.

What is the dividend of Twist Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Twist Bioscience located?

Twist Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Twist Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Twist Bioscience from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did Twist Bioscience pay the last dividend?

The last dividend was paid out on 9/10/2024.

What was the dividend of Twist Bioscience in the year 2023?

In the year 2023, Twist Bioscience distributed 0 USD as dividends.

In which currency does Twist Bioscience pay out the dividend?

The dividends of Twist Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Twist Bioscience stock can be added to a savings plan with the following providers: Scalable Capital

Andere Kennzahlen von Twist Bioscience

Our stock analysis for Twist Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Twist Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.